Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections

Yonsei Medical Journal - Tập 63 Số 7 - Trang 611 - 2022
Yeonju La1, Hye Rim Kim2, Dong Hyun Oh3, Jin Young Ahn4, Yong Chan Kim5
1Department of Internal Medicine, Kangwon National University Hospital, Chuncheon, Korea.
2Biostatistics Collaboration Unit, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea
3Department of Internal Medicine, Seoul Medical Center, Seoul, Korea
4Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
5Department of Internal Medicine, Division of Infectious Disease, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Kern, 2020, Clin Microbiol Infect, 26, 151, 10.1016/j.cmi.2019.10.031

Gagliotti, 2021, Euro Surveill, 26, 2002094, 10.2807/1560-7917.ES.2021.26.46.2002094

van Hal, 2012, Clin Microbiol Rev, 25, 362, 10.1128/CMR.05022-11

Lam, 2019, Infection, 47, 961, 10.1007/s15010-019-01330-5

Liu, 2011, Clin Infect Dis, 52, e18, 10.1093/cid/ciq146

Kim, 2015, Antimicrob Agents Chemother, 59, 811, 10.1128/AAC.04523-14

Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, 51, 565

Lodise, 2008, Antimicrob Agents Chemother, 52, 1330, 10.1128/AAC.01602-07

Stryjewski, 2007, Clin Infect Dis, 44, 190, 10.1086/510386

Kim, 2008, Antimicrob Agents Chemother, 52, 192, 10.1128/AAC.00700-07

Schweizer, 2011, BMC Infect Dis, 11, 279, 10.1186/1471-2334-11-279

Horan, 2008, Am J Infect Control, 36, 309, 10.1016/j.ajic.2008.03.002

Paterson, 2004, Clin Infect Dis, 39, 31, 10.1086/420816

Hilf, 1989, Am J Med, 87, 540, 10.1016/S0002-9343(89)80611-4

Vallés, 1997, Clin Infect Dis, 24, 387, 10.1093/clinids/24.3.387

Fowler, 2004, J Infect Dis, 190, 1140, 10.1086/423145

Bosso, 2011, Antimicrob Agents Chemother, 55, 5475, 10.1128/AAC.00168-11

Youngster, 2014, Clin Infect Dis, 59, 369, 10.1093/cid/ciu301

Yaw, 2014, Lancet Infect Dis, 14, 967, 10.1016/S1473-3099(14)70876-X

Braquet, 2016, Clin Microbiol Infect, 22, 948.e1, 10.1016/j.cmi.2016.07.034

Nambiar, 2018, J Infect, 77, 516, 10.1016/j.jinf.2018.08.015

Austin, 2015, Stat Med, 34, 3661, 10.1002/sim.6607

Chang, 2003, Medicine (Baltimore), 82, 333, 10.1097/01.md.0000091184.93122.09

Turnidge, 2009, Med J Aust, 191, 368, 10.5694/j.1326-5377.2009.tb02841.x

Ruth, 2015, Long-term outcomes of Manitoba’s insight mentoring program: a comparative statistical analysis

Kourtis, 2019, MMWR Morb Mortal Wkly Rep, 68, 214, 10.15585/mmwr.mm6809e1

Choi, 2021, J Korean Med Sci, 36, e104, 10.3346/jkms.2021.36.e104

Kim, 2014, BMC Infect Dis, 14, 590, 10.1186/s12879-014-0590-4

Lee, 2018, Euro Surveill, 23, 1800047

Wong, 2016, Ann Clin Microbiol Antimicrob, 15, 27, 10.1186/s12941-016-0143-3

Park, 2017, Eur J Clin Microbiol Infect Dis, 36, 1091, 10.1007/s10096-016-2893-4

Cantoni, 1990, Antimicrob Agents Chemother, 34, 2348, 10.1128/AAC.34.12.2348

Dahlgren, 1997, Am J Health Syst Pharm, 54, 1176, 10.1093/ajhp/54.10.1176

Henson, 2015, Expert Rev Anti Infect Ther, 13, 1265, 10.1586/14787210.2015.1068118

LaPlante, 2004, Antimicrob Agents Chemother, 48, 4665, 10.1128/AAC.48.12.4665-4672.2004

Rybak, 2006, Clin Infect Dis, 42 Suppl 1, S35, 10.1086/491712